BlackRock Institutional Trust’s Galectin Therapeutics GALT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2016
Q4 | $41K | Hold |
42,034
| – | – | ﹤0.01% | 3699 |
|
2016
Q3 | $47K | Hold |
42,034
| – | – | ﹤0.01% | 3721 |
|
2016
Q2 | $62K | Hold |
42,034
| – | – | ﹤0.01% | 3734 |
|
2016
Q1 | $60K | Hold |
42,034
| – | – | ﹤0.01% | 3746 |
|
2015
Q4 | $69K | Hold |
42,034
| – | – | ﹤0.01% | 3775 |
|
2015
Q3 | $98K | Hold |
42,034
| – | – | ﹤0.01% | 3715 |
|
2015
Q2 | $115K | Sell |
42,034
-115,508
| -73% | -$316K | ﹤0.01% | 3687 |
|
2015
Q1 | $528K | Sell |
157,542
-2,664
| -2% | -$8.93K | ﹤0.01% | 3481 |
|
2014
Q4 | $556K | Sell |
160,206
-11,052
| -6% | -$38.4K | ﹤0.01% | 3466 |
|
2014
Q3 | $861K | Sell |
171,258
-29,847
| -15% | -$150K | ﹤0.01% | 3356 |
|
2014
Q2 | $2.78M | Buy |
201,105
+195,312
| +3,372% | +$2.7M | ﹤0.01% | 3032 |
|
2014
Q1 | $89K | Buy |
+5,793
| New | +$89K | ﹤0.01% | 3757 |
|